Cargando…
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
Pancreatic cancer has one of the worst prognoses among all cancers due to the late manifestation of identifiable symptoms and high resistance to chemo- and radiation therapies. In recent years, a cancer development phase termed epithelial-mesenchymal transition (EMT) has gained increasing research f...
Autores principales: | Elaskalani, Omar, Razak, Norbaini Binti Abdol, Falasca, Marco, Metharom, Pat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241525/ https://www.ncbi.nlm.nih.gov/pubmed/28144398 http://dx.doi.org/10.4251/wjgo.v9.i1.37 |
Ejemplares similares
-
Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells
por: Elaskalani, Omar, et al.
Publicado: (2020) -
Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones
por: Elaskalani, Omar, et al.
Publicado: (2018) -
Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis
por: Abdol Razak, Norbaini, et al.
Publicado: (2017) -
Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
por: Hu, Xiu, et al.
Publicado: (2021) -
The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance
por: Elaskalani, Omar, et al.
Publicado: (2017)